Sergei V. Borisevich

1 ta ish

27th Central Research Institute of the Ministry of Defence of the Russian Federation

1. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

   Denis Y. Logunov, Inna V. Dolzhikova, Dmitry V. Shcheblyakov +28

   Maqola20216 iqtibos

   ABIABI:AkademIndex/2026.other.554498